174 related articles for article (PubMed ID: 23517183)
1. Interaction of anticancer ruthenium compounds with proteins: high-resolution X-ray structures and raman microscopy studies of the adduct between hen egg white lysozyme and AziRu.
Vergara A; D'Errico G; Montesarchio D; Mangiapia G; Paduano L; Merlino A
Inorg Chem; 2013 Apr; 52(8):4157-9. PubMed ID: 23517183
[TBL] [Abstract][Full Text] [Related]
2. Ruthenium metalation of proteins: the X-ray structure of the complex formed between NAMI-A and hen egg white lysozyme.
Messori L; Merlino A
Dalton Trans; 2014 Apr; 43(16):6128-31. PubMed ID: 24553967
[TBL] [Abstract][Full Text] [Related]
3. The mode of action of anticancer gold-based drugs: a structural perspective.
Messori L; Scaletti F; Massai L; Cinellu MA; Gabbiani C; Vergara A; Merlino A
Chem Commun (Camb); 2013 Oct; 49(86):10100-2. PubMed ID: 24045294
[TBL] [Abstract][Full Text] [Related]
4. Ruthenium anticancer drugs and proteins: a study of the interactions of the ruthenium(III) complex imidazolium trans-[tetrachloro(dimethyl sulfoxide)(imidazole)ruthenate(III)] with hen egg white lysozyme and horse heart cytochrome c.
Casini A; Mastrobuoni G; Terenghi M; Gabbiani C; Monzani E; Moneti G; Casella L; Messori L
J Biol Inorg Chem; 2007 Nov; 12(8):1107-17. PubMed ID: 17680283
[TBL] [Abstract][Full Text] [Related]
5. A comparative study of adduct formation between the anticancer ruthenium(III) compound HInd trans-[RuCl4(Ind)2] and serum proteins.
Piccioli F; Sabatini S; Messori L; Orioli P; Hartinger ChG; Keppler BK
J Inorg Biochem; 2004 Jun; 98(6):1135-42. PubMed ID: 15149825
[TBL] [Abstract][Full Text] [Related]
6. Characterization of a ruthenium(III)/NAMI-A adduct with bovine serum albumin that exhibits a high anti-metastatic activity.
Liu M; Lim ZJ; Gwee YY; Levina A; Lay PA
Angew Chem Int Ed Engl; 2010 Feb; 49(9):1661-4. PubMed ID: 20127775
[No Abstract] [Full Text] [Related]
7. EPR as a probe of the intracellular speciation of ruthenium(III) anticancer compounds.
Webb MI; Walsby CJ
Metallomics; 2013 Dec; 5(12):1624-33. PubMed ID: 24057014
[TBL] [Abstract][Full Text] [Related]
8. Re(CO)(3)(H(2)O)(3)(+) binding to lysozyme: structure and reactivity.
Binkley SL; Leeper TC; Rowlett RS; Herrick RS; Ziegler CJ
Metallomics; 2011 Sep; 3(9):909-16. PubMed ID: 21805003
[TBL] [Abstract][Full Text] [Related]
9. Biophysical characterisation of adducts formed between anticancer metallodrugs and selected proteins: new insights from X-ray diffraction and mass spectrometry studies.
Casini A; Guerri A; Gabbiani C; Messori L
J Inorg Biochem; 2008; 102(5-6):995-1006. PubMed ID: 18289690
[TBL] [Abstract][Full Text] [Related]
10. Investigating the ruthenium metalation of proteins: X-ray structure and Raman microspectroscopy of the complex between RNase A and AziRu.
Vergara A; Russo Krauss I; Montesarchio D; Paduano L; Merlino A
Inorg Chem; 2013 Oct; 52(19):10714-6. PubMed ID: 24093479
[TBL] [Abstract][Full Text] [Related]
11. ESI mass spectrometry and X-ray diffraction studies of adducts between anticancer platinum drugs and hen egg white lysozyme.
Casini A; Mastrobuoni G; Temperini C; Gabbiani C; Francese S; Moneti G; Supuran CT; Scozzafava A; Messori L
Chem Commun (Camb); 2007 Jan; (2):156-8. PubMed ID: 17180231
[TBL] [Abstract][Full Text] [Related]
12. CORM-3 reactivity toward proteins: the crystal structure of a Ru(II) dicarbonyl-lysozyme complex.
Santos-Silva T; Mukhopadhyay A; Seixas JD; Bernardes GJ; Romão CC; Romão MJ
J Am Chem Soc; 2011 Feb; 133(5):1192-5. PubMed ID: 21204537
[TBL] [Abstract][Full Text] [Related]
13. Structural studies of the effect that dimethyl sulfoxide (DMSO) has on cisplatin and carboplatin binding to histidine in a protein.
Tanley SW; Schreurs AM; Kroon-Batenburg LM; Meredith J; Prendergast R; Walsh D; Bryant P; Levy C; Helliwell JR
Acta Crystallogr D Biol Crystallogr; 2012 May; 68(Pt 5):601-12. PubMed ID: 22525758
[TBL] [Abstract][Full Text] [Related]
14. A spectroscopic study of the reaction of NAMI, a novel ruthenium(III)anti-neoplastic complex, with bovine serum albumin.
Messori L; Orioli P; Vullo D; Alessio E; Iengo E
Eur J Biochem; 2000 Feb; 267(4):1206-13. PubMed ID: 10672032
[TBL] [Abstract][Full Text] [Related]
15. Interaction of apo-transferrin with anticancer ruthenium complexes NAMI-A and its reduced form.
Mazuryk O; Kurpiewska K; Lewiński K; Stochel G; Brindell M
J Inorg Biochem; 2012 Nov; 116():11-8. PubMed ID: 23010324
[TBL] [Abstract][Full Text] [Related]
16. High-resolution crystal structures of a "half sandwich"-type Ru(II) coordination compound bound to hen egg-white lysozyme and proteinase K.
Chiniadis L; Bratsos I; Bethanis K; Karpusas M; Giastas P; Papakyriakou A
J Biol Inorg Chem; 2020 Jun; 25(4):635-645. PubMed ID: 32266561
[TBL] [Abstract][Full Text] [Related]
17. Structure-activity relationships for NAMI-A-type complexes (HL)[trans-RuCl4L(S-dmso)ruthenate(III)] (L = imidazole, indazole, 1,2,4-triazole, 4-amino-1,2,4-triazole, and 1-methyl-1,2,4-triazole): aquation, redox properties, protein binding, and antiproliferative activity.
Groessl M; Reisner E; Hartinger CG; Eichinger R; Semenova O; Timerbaev AR; Jakupec MA; Arion VB; Keppler BK
J Med Chem; 2007 May; 50(9):2185-93. PubMed ID: 17402720
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, structural characterization, solution chemistry, and preliminary biological studies of the ruthenium(III) complexes [TzH][trans-RuCl4(Tz)2] and [TzH][trans-RuCl4(DMSO)(Tz)].(DMSO), the thiazole analogues of antitumor ICR and NAMI-A.
Mura P; Camalli M; Messori L; Piccioli F; Zanello P; Corsini M
Inorg Chem; 2004 Jun; 43(13):3863-70. PubMed ID: 15206867
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and X-ray Structural Analysis of the Ruthenium(III) Complex Na[trans-RuCl4(DMSO) (PyrDiaz)], the Diazene Derivative of Antitumor NAMI-Pyr.
Vajs J; Pevec A; Gazvoda M; Urankar D; Goreshnik E; Polanc S; Košmrlj J
Acta Chim Slov; 2017 Dec; 64(4):763-770. PubMed ID: 29318318
[TBL] [Abstract][Full Text] [Related]
20. RNA binding and inhibition of primer extension by a Ru(III)/Pt(II) metal complex.
Jain SS; Anderson CM; DiRienzo F; Taylor IR; Jain K; Guha S; Hoque N
Chem Commun (Camb); 2013 Jun; 49(44):5031-3. PubMed ID: 23615723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
